Cargando…
The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma
BACKGROUND: Gallbladder cancer is the most common billiary tract malignancy and carries a very poor prognosis. Somatostatin was recently shown to play an important role in the development of various tumors. In the current study, we evaluated the effect of doxorubicin on the chemosensitivity of gallb...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1931603/ https://www.ncbi.nlm.nih.gov/pubmed/17617924 http://dx.doi.org/10.1186/1471-2407-7-125 |